Multi-omic analysis of stroke recurrence in African Americans from the Vitamin Intervention for Stroke Prevention (VISP) clinical trial.
Multi-omic analysis of stroke recurrence in African Americans from the Vitamin Intervention for Stroke Prevention (VISP) clinical trial.
复制标题
DOI：
10.1371/journal.pone.0247257
复制
发表时间：
2021
期刊：
影响因子：
3.7
通讯作者：
Keene KL
中科院分区：
文献类型：
--
作者：
Davis Armstrong NM;Spragley KJ;Chen WM;Hsu FC;Brewer MS;Horn PJ;Williams SR;Sale MM;Worrall BB;Keene KL
African Americans endure a nearly two-fold greater risk of suffering a stroke and are 2–3 times more likely to die from stroke compared to those of European ancestry. African Americans also have a greater risk of recurrent stroke and vascular events, which are deadlier and more disabling than incident stroke. Stroke is a multifactorial disease with both heritable and environmental risk factors. We conducted an integrative, multi-omic study on 922 plasma metabolites, 473,864 DNA methylation loci, and 556 variants from 50 African American participants of the Vitamin Intervention for Stroke Prevention clinical trial to help elucidate biomarkers contributing to recurrent stroke rates in this high risk population. Sixteen metabolites, including cotinine, N-delta-acetylornithine, and sphingomyelin (d17:1/24:1) were identified in t-tests of recurrent stroke outcome or baseline smoking status. Serum tricosanoyl sphingomyelin (d18:1/23:0) levels were significantly associated with recurrent stroke after adjusting for covariates in Cox Proportional Hazards models. Weighted Gene Co-expression Network Analysis identified moderate correlations between sphingolipid markers and clinical traits including days to recurrent stroke. Integrative analyses between genetic variants in sphingolipid pathway genes identified 29 nominal associations with metabolite levels in a one-way analysis of variance, while epigenomic analyses identified xenobiotics, predominately smoking-associated metabolites and pharmaceutical drugs, associated with methylation profiles. Taken together, our results suggest that metabolites, specifically those associated with sphingolipid metabolism, are potential plasma biomarkers for stroke recurrence in African Americans. Furthermore, genetic variation and DNA methylation may play a role in the regulation of these metabolites.
登录
查看更多内容
WGCNA：用于加权相关网络分析的 R 包。
影响因子：
3
作者：
Langfelder P;Horvath S
通讯作者：
Horvath S
影响因子：
14.9
作者：
Kim S;Chen J;Cheng T;Gindulyte A;He J;He S;Li Q;Shoemaker BA;Thiessen PA;Yu B;Zaslavsky L;Zhang J;Bolton EE
通讯作者：
Bolton EE
影响因子：
0.8
作者：
Nayak-Rao S;Shenoy MP
通讯作者：
Shenoy MP
影响因子：
3.7
作者：
Spijkers LJ;van den Akker RF;Janssen BJ;Debets JJ;De Mey JG;Stroes ES;van den Born BJ;Wijesinghe DS;Chalfant CE;MacAleese L;Eijkel GB;Heeren RM;Alewijnse AE;Peters SL
通讯作者：
Peters SL
影响因子：
5.7
作者：
Chan, Su Jing;Ng, Mary P. E.;Seet, Raymond C. S.
通讯作者：
Seet, Raymond C. S.